Article Details

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval - News-Medical

Retrieved on: 2024-04-26 17:13:42

Tags for this article:

Click the tags to see associated articles and topics

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval - News-Medical. View article details on HISWAI: https://www.news-medical.net/news/20240425/Insilico-Medicines-AI-designed-drug-ISM3412-receives-FDA-IND-approval.aspx

Summary

Generative Adversarial Networks (GANs) were used by Insilico Medicine to design ISM3412, an MAT2A inhibitor for treating MTAP-deleted cancers, now approved for Phase I trials by the FDA. This aligns with the tags 'Synthetic lethality,' 'Cancer treatment,' and 'MTAP.'

Article found on: www.news-medical.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up